We publish high-quality original research in Hepatology / Co-EICs @lucavalenti75 @AghemoAlessio @Alexfornergon / IF=6.0 / RT ≠ endorsment

Joined November 2012
524 Photos and videos
Liver International retweeted
You can continue #Anticoagulation when you perform #endoscopicbandligation #ELB for #varices When Undergoing Endoscopic Variceal Ligation: A Systematic Review and Meta‐Analysis @LiverInt 🔗onlinelibrary.wiley.com/doi/…
2
28
63
6,822
Liver International retweeted
Anticoagulation did 🚫increase the risk of bleeding With/without anticoagulation during EVL, we found a similar risk of: 1) Overall bleeding 2) Severe bleeding 3) Post-banding ulcer bleeding #Livertwitter 👉doi.org/10.1111/liv.16188
Indeed, the practice of anticoagulation is heterogeneous. We recently summarized the existing studies looking at the safety of anticoagulation in patients undergoing EVL 👉doi.org/10.1111/liv.16188 Anticoagulation did 🚫increase the risk of bleeding
1
16
40
4,848
Liver International retweeted
Very excited to have the final paper from my #PhD published #OpenAccess in @LiverInt While #HCV DAA treatment is highly effective, it is important to understand why a small minority are not cured. We aimed to do this with data from 🇦🇺🇨🇦🇫🇷🇳🇱🇪🇸🇨🇭 onlinelibrary.wiley.com/doi/…
4
7
891
Liver International retweeted
In this @LiverInt study, researchers from #Japan shed light on how #MICOS defects impair #mitochondrial function in #MitochondrialDNAdepletionSyndrome, opening new avenues for genetic testing and therapies. Learn more: doi.org/10.1111/liv.16148
3
9
115
146,136
1/2 ⬆️ liver tests may not always indicate a higher risk of serious liver disease Genetic variants influencing common liver test results (like GGT & bilirubin) don't always correlate with higher cirrhosis risk 🤔 🔓bit.ly/3VgbxO4 #livertwitter
1
11
16
2,829
2/2 💡 The clinical impact? Using genetics to interpret LBTs may reduce false positives/negatives, optimize resources, and improve diagnostics further validation in diverse populations is needed! 🌍🩺 #livertwitter
2
542
Liver International retweeted
G-CSF is not inferior to corticosteroids in improving 90-day overall survival and 6-months transplant free survival in patients with severe alcohol-associated hepatitis. Singh et Al @LiverInt onlinelibrary.wiley.com/doi/… #livertwitter #GITwitter
3
6
899
Liver International retweeted
🚨 New Research Alert! 🚨 Latest paper in @LiverInt by the @OhioStateSurg TEAM explores the impact of #GLP1RA on adverse liver outcomes among patients with #Alcohol associated #liver disease and type 2 #diabetes Link 👉 doi.org/10.1111/liv.16132 💡Key finding GLP-1RA = ⬇️ incidence of adverse liver outcome particularly #hepatic #decompensation @timpawlik #MedTwitter @ProjectImg
4
10
1,222
Liver International retweeted
11 Oct 2024
Necesidades no cubiertas en pacientes con hepatitis autoinmune (y son unas cuantas): 👉 Solo el 62% de los pacientes logran respuesta completa tras 1 año de tto ⚠️ Apenas el 27% lo consigue sin esteroides 🔄 30% de los pacientes cambian de tratamiento por intolerancia o no respuesta 📉 Heterogeneidad extrema en los tratamientos entre centros ❌ Necesitamos más alternativas terapéuticas efectivas y seguras 🔓 doi.org/10.1111/liv.16035 en @LiverInt Detalle relevante: tampoco debería sorprendernos, el tto estándar tiene 50 años! #livertwitter #HAI
1
18
38
2,555
Liver International retweeted
🚨#livertwitter #Hepatitis #HCV #Elimination 🇦🇹 Austrian #HCV Elimination Project supported @GileadSciences 5695 #HCV patients screened 397 started on #Antivirals #DAA 326 #HCV patients cured #SVR#HepC Cure 😇 Survival Benefit 📕@LiverInt 🔗t.ly/UFbQ6
1
3
16
1,566
Liver International retweeted
New insights into liver fibrosis in @LiverInt! SHG/TPEF microscopy with #AI offers precise assessment of #fibrosis in MASH F3 patients, revealing changes even when standard scoring shows 'no change.' #livertwitter @DavidKleiner12 bit.ly/3Tyu8nG
6
21
1,261
Liver International retweeted
“The Liver would be better” The story behind Neruda’s ode to the liver by @MarcoArreseMD in @LiverInt onlinelibrary.wiley.com/doi/…
4
16
49
5,201
1/2 A multicenter 🇪🇸 study shows that #Rituximab is a safe & effective option for patients with refractory autoimmune hepatitis It achieved complete biochemical response in 89% of cases, ⬇️ need for immunosuppressants & corticosteroids 🔓 bit.ly/4ehFh4u #Livertwitter
1
35
109
11,382
2/2 ‼️ Despite its efficacy, 31% of patients experienced relapses, successfully managed with additional Rituximab cycles While promising, prospective studies are needed to validate these findings in advanced #AIH #livertwitter
4
11
1,192